Status:
COMPLETED
Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries
Lead Sponsor:
Bayer
Conditions:
Wound Healing
Cell Proliferation
Eligibility:
All Genders
18-45 years
Phase:
PHASE4
Brief Summary
In previous in vitro studies it could be shown, that Dexpanthenol has an influence on the gene expression of fibroblasts. The genes which are influenced by Dexpanthenol play mainly a role during cell ...
Eligibility Criteria
Inclusion
- Skin type I to IV
- Willingness to avoid intensive sunlight exposure two weeks before the start of the study and at least 2 months after removal of the stitches
Exclusion
- Active skin disease, moles, tattoos, strong pigmentation at the test area or scars in the test area that would influence the visual scoring
- History of keloids and hypertrophic scars
- Frequent visits of tanning booths
- Intake of drugs interfering with the immune system (e.g. antiphlogistics, corticosteroids, immunosuppressants, and antihistamines) within 30 days before day 1 as well as during the study.
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00859196
Start Date
February 1 2009
End Date
March 1 2009
Last Update
December 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamburg, Hamburg, Germany, 22869